State Street Corp Ampio Pharmaceuticals, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $450,358 - $1.32 Million	-2,814,743 Reduced 82.04%	616,027 $103,000
Q1 2022 May 16, 2022	BUY	$0.42 - $0.62 $27,877 - $41,152	66,375 Added 1.97%	3,430,770 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $36,733 - $112,169	-65,596 Reduced 1.91%	3,364,395 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $765,552 - $1.14 Million	632,688 Added 22.62%	3,429,991 $5.69 Million
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $4.28 Million - $5.43 Million	2,741,165 Added 4882.9%	2,797,303 $4.67 Million
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $6,975 - $25,667	9,300 Added 19.86%	56,138 $89,000
Q1 2020 May 11, 2020	BUY	$0.36 - $0.74 $16,861 - $34,660	46,838 New	46,838 $19,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.